Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice

Masashi Inafuku, Koji Nagao, Saori Nomura, Bungo Shirouchi, Nao Inoue, Naoki Nagamori, Hideyuki Nakayama, Takayoshi Toda, Teruyoshi Yanagita

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common liver disease in industrialised countries. Various mushrooms have been used in Eastern folk medicine for the treatment of lifestyle diseases. We previously found that the dietary intake of powdered whole Panellus serotinus (Mukitake) alleviates NAFLD in obese, diabetic db/db mice. In the present study, we investigated the influence of Mukitake fractional extracts on the development of NAFLD in db/db mice. A significant reduction in the hepatic TAG content, macrovesicular hepatocytes and activities of key enzymes for de novo synthesis of the fatty acid was observed in both the water-soluble Mukitake extract (WE) diet and the ethanol-soluble Mukitake extract (EE) diet groups compared with the control diet group of the db/db mice. The serum level of monocyte chemoattractant protein-1 (MCP-1), which is known to exacerbate insulin resistance, was significantly decreased in the WE group. On the other hand, the serum level of adiponectin, which plays a protective role against the metabolic syndrome, was significantly increased in the EE group. Additionally, differential analysis between Mukitake and Shiitake, mycelia from the same family, using liquid chromatography time-of-flight MS technology revealed that only seven and five compounds exist in WE and EE from Mukitake, respectively. In conclusion, the present study demonstrated that Mukitake displays at least two different physiological actions that alleviate NAFLD: one through the reduction in inflammatory damage by its suppression in MCP-1 production and the other through an increase in level of serum adiponectin and the prevention of visceral fat accumulation.

Original languageEnglish
Pages (from-to)639-646
Number of pages8
JournalBritish Journal of Nutrition
Volume107
Issue number5
DOIs
Publication statusPublished - Mar 14 2012

Fingerprint

Ethanol
Chemokine CCL2
Adiponectin
Diet
Water
Serum
Intra-Abdominal Fat
Agaricales
Mycelium
Traditional Medicine
Developed Countries
Liquid Chromatography
Insulin Resistance
Life Style
Liver Diseases
Hepatocytes
Fatty Acids
Technology
Control Groups
Non-alcoholic Fatty Liver Disease

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice. / Inafuku, Masashi; Nagao, Koji; Nomura, Saori; Shirouchi, Bungo; Inoue, Nao; Nagamori, Naoki; Nakayama, Hideyuki; Toda, Takayoshi; Yanagita, Teruyoshi.

In: British Journal of Nutrition, Vol. 107, No. 5, 14.03.2012, p. 639-646.

Research output: Contribution to journalArticle

Inafuku, Masashi ; Nagao, Koji ; Nomura, Saori ; Shirouchi, Bungo ; Inoue, Nao ; Nagamori, Naoki ; Nakayama, Hideyuki ; Toda, Takayoshi ; Yanagita, Teruyoshi. / Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice. In: British Journal of Nutrition. 2012 ; Vol. 107, No. 5. pp. 639-646.
@article{aaf763c57a67481c82c1df3c9be7b854,
title = "Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice",
abstract = "Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common liver disease in industrialised countries. Various mushrooms have been used in Eastern folk medicine for the treatment of lifestyle diseases. We previously found that the dietary intake of powdered whole Panellus serotinus (Mukitake) alleviates NAFLD in obese, diabetic db/db mice. In the present study, we investigated the influence of Mukitake fractional extracts on the development of NAFLD in db/db mice. A significant reduction in the hepatic TAG content, macrovesicular hepatocytes and activities of key enzymes for de novo synthesis of the fatty acid was observed in both the water-soluble Mukitake extract (WE) diet and the ethanol-soluble Mukitake extract (EE) diet groups compared with the control diet group of the db/db mice. The serum level of monocyte chemoattractant protein-1 (MCP-1), which is known to exacerbate insulin resistance, was significantly decreased in the WE group. On the other hand, the serum level of adiponectin, which plays a protective role against the metabolic syndrome, was significantly increased in the EE group. Additionally, differential analysis between Mukitake and Shiitake, mycelia from the same family, using liquid chromatography time-of-flight MS technology revealed that only seven and five compounds exist in WE and EE from Mukitake, respectively. In conclusion, the present study demonstrated that Mukitake displays at least two different physiological actions that alleviate NAFLD: one through the reduction in inflammatory damage by its suppression in MCP-1 production and the other through an increase in level of serum adiponectin and the prevention of visceral fat accumulation.",
author = "Masashi Inafuku and Koji Nagao and Saori Nomura and Bungo Shirouchi and Nao Inoue and Naoki Nagamori and Hideyuki Nakayama and Takayoshi Toda and Teruyoshi Yanagita",
year = "2012",
month = "3",
day = "14",
doi = "10.1017/S0007114511003485",
language = "English",
volume = "107",
pages = "639--646",
journal = "British Journal of Nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "5",

}

TY - JOUR

T1 - Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice

AU - Inafuku, Masashi

AU - Nagao, Koji

AU - Nomura, Saori

AU - Shirouchi, Bungo

AU - Inoue, Nao

AU - Nagamori, Naoki

AU - Nakayama, Hideyuki

AU - Toda, Takayoshi

AU - Yanagita, Teruyoshi

PY - 2012/3/14

Y1 - 2012/3/14

N2 - Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common liver disease in industrialised countries. Various mushrooms have been used in Eastern folk medicine for the treatment of lifestyle diseases. We previously found that the dietary intake of powdered whole Panellus serotinus (Mukitake) alleviates NAFLD in obese, diabetic db/db mice. In the present study, we investigated the influence of Mukitake fractional extracts on the development of NAFLD in db/db mice. A significant reduction in the hepatic TAG content, macrovesicular hepatocytes and activities of key enzymes for de novo synthesis of the fatty acid was observed in both the water-soluble Mukitake extract (WE) diet and the ethanol-soluble Mukitake extract (EE) diet groups compared with the control diet group of the db/db mice. The serum level of monocyte chemoattractant protein-1 (MCP-1), which is known to exacerbate insulin resistance, was significantly decreased in the WE group. On the other hand, the serum level of adiponectin, which plays a protective role against the metabolic syndrome, was significantly increased in the EE group. Additionally, differential analysis between Mukitake and Shiitake, mycelia from the same family, using liquid chromatography time-of-flight MS technology revealed that only seven and five compounds exist in WE and EE from Mukitake, respectively. In conclusion, the present study demonstrated that Mukitake displays at least two different physiological actions that alleviate NAFLD: one through the reduction in inflammatory damage by its suppression in MCP-1 production and the other through an increase in level of serum adiponectin and the prevention of visceral fat accumulation.

AB - Non-alcoholic fatty liver disease (NAFLD) is emerging as the most common liver disease in industrialised countries. Various mushrooms have been used in Eastern folk medicine for the treatment of lifestyle diseases. We previously found that the dietary intake of powdered whole Panellus serotinus (Mukitake) alleviates NAFLD in obese, diabetic db/db mice. In the present study, we investigated the influence of Mukitake fractional extracts on the development of NAFLD in db/db mice. A significant reduction in the hepatic TAG content, macrovesicular hepatocytes and activities of key enzymes for de novo synthesis of the fatty acid was observed in both the water-soluble Mukitake extract (WE) diet and the ethanol-soluble Mukitake extract (EE) diet groups compared with the control diet group of the db/db mice. The serum level of monocyte chemoattractant protein-1 (MCP-1), which is known to exacerbate insulin resistance, was significantly decreased in the WE group. On the other hand, the serum level of adiponectin, which plays a protective role against the metabolic syndrome, was significantly increased in the EE group. Additionally, differential analysis between Mukitake and Shiitake, mycelia from the same family, using liquid chromatography time-of-flight MS technology revealed that only seven and five compounds exist in WE and EE from Mukitake, respectively. In conclusion, the present study demonstrated that Mukitake displays at least two different physiological actions that alleviate NAFLD: one through the reduction in inflammatory damage by its suppression in MCP-1 production and the other through an increase in level of serum adiponectin and the prevention of visceral fat accumulation.

UR - http://www.scopus.com/inward/record.url?scp=84856738343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856738343&partnerID=8YFLogxK

U2 - 10.1017/S0007114511003485

DO - 10.1017/S0007114511003485

M3 - Article

C2 - 21787451

AN - SCOPUS:84856738343

VL - 107

SP - 639

EP - 646

JO - British Journal of Nutrition

JF - British Journal of Nutrition

SN - 0007-1145

IS - 5

ER -